US4128612A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Making absorbable surgical felt
Assignee: Wyeth Holdings LLC
•
Filing: 1975-11-03
•
Granted: 1978-12-05
•
Expires: 1995-11-03
Abstract
Abstract Tissue absorbable synthetic polymeric fibers, such as polyglycolic acid, are felted to form a thin mat with at least one, and preferably both, surfaces compacted by contact with a heated embossing surface such as a hot roller. Porosity is reduced but the compacted felt retains its flexibility, and conforms readily to the surface of a bleeding wound to give effective rapid hemostasis. The hemostatic felt is conveniently but not necessarily allowed to remain in place during the healing process and is absorbed by living tissue.
Inventors
- 👤 Roy W. Roth
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-22 19:35
CPC Classifications
A; A61; A61L; A61L15/00; A61L15/16; A61L15/42; A61L15/64; A61L27/00; A61L27/50; A61L27/58; A61L2400/00; A61L2400/04
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
133 words
A method of making sterile hemostatic surgical felt, having a textured and embossed surface, consisting entirely of a living tissue absorbable polymer which comprises: spinning a living tissue absorbable polymer into fibers of 0.5 to 12 denier, cutting said fibers into segments of from about 1/4 inch to about 3 inches in length, randomly air laying said fibers into a mat having a uniform density of from about 0.5 to about 4 ounces per square yard, heating and compressing with a texture surface to emboss said mat and bind the fibers to form a felt, the heating, embossing and texturing causing a reduction in the rate of blood penetration, and improving the adhesion to bleeding surfaces, cutting to form individual felt hemostats, and, in any order, packaging in contamination resistant packages, and sterilizing.
Claim 2
Independent Claim
133 words
A method of making sterile hemostatic surgical felt, having a textured and embossed surface, consisting entirely of a living tissue absorbable polymer which comprises: spinning a living tissue absorbable polymer into fibers of 0.5 to 12 denier, cutting said fibers into segments of from about 1/4 inch to about 3 inches in length, randomly air laying said fibers into a mat having a uniform density of from about 0.5 to about 4 ounces per square yard, heating and compressing with a texture surface to emboss said mat and bind the fibers to form a felt, the heating, embossing and texturing causing a reduction in the rate of blood penetration, and improving the adhesion to bleeding surfaces, cutting to form individual felt hemostats, and, in any order, packaging in contamination resistant packages, and sterilizing.
Claim 3
Dependent Claim
23 words
The method of claim 1 in which the individual felt hemostats are packaged in moisture proof strippable packages, and sterilized by ethylene oxide.
Claim 4
Dependent Claim
38 words
The method of claim 2 in which the living tissue absorbable polymer has glycolic acid ester linkages, is melt spun, and has a greatly reduced permeability to air due to embossing and heat compressing between heated embossing rolls.
Claim 5
Independent Claim
239 words
A method of making a sterile hemostatic surgical felt, having a textured and embossed surface, consisting entirely of a living tissue absorbable polymer of glycolic acid which comprises: melt spinning a living tissue absorbable polymer of glycolic acid into fibers of 0.5 to 12 denier, cutting said fibers into segments of from about 1/4 inches to about 3 inches in length, randomly air laying said fibers into a mat having a uniform density of about 2.25 ounces per square yard, heating and compressing between heated embossing rolls, at least one of which has a textured surface to emboss said mat and bind the fibers to form a felt, having a stiffness of 1.05 to 1.83 inches, measured as one half the length of the overhang of a specimen on a flat horizontal surface which drops to an angle of 411/2° , and which before embossing is too fragile for stiffness measurement, and an air permeability of about 135 cubic feet per minute per square foot at 0.5 inches of water pressure differential, and which before embossing has an air permeability of about 360 cubic feet per minute per square foot at 0.5 inches of water pressure differential whereby the rate of penetration of blood is reduced, and the adhesion to bleeding surfaces enhanced, and which is completely absorbed when enclosed in living tissue, cutting to form individual felt hemostats, and, in any order packaging in contamination resistant packages, sterilizing.
Claim 6
Independent Claim
239 words
A method of making a sterile hemostatic surgical felt, having a textured and embossed surface, consisting entirely of a living tissue absorbable polymer of glycolic acid which comprises: melt spinning a living tissue absorbable polymer of glycolic acid into fibers of 0.5 to 12 denier, cutting said fibers into segments of from about 1/4 inches to about 3 inches in length, randomly air laying said fibers into a mat having a uniform density of about 2.25 ounces per square yard, heating and compressing between heated embossing rolls, at least one of which has a textured surface to emboss said mat and bind the fibers to form a felt, having a stiffness of 1.05 to 1.83 inches, measured as one half the length of the overhang of a specimen on a flat horizontal surface which drops to an angle of 411/2° , and which before embossing is too fragile for stiffness measurement, and an air permeability of about 135 cubic feet per minute per square foot at 0.5 inches of water pressure differential, and which before embossing has an air permeability of about 360 cubic feet per minute per square foot at 0.5 inches of water pressure differential whereby the rate of penetration of blood is reduced, and the adhesion to bleeding surfaces enhanced, and which is completely absorbed when enclosed in living tissue, cutting to form individual felt hemostats, and, in any order packaging in contamination resistant packages, sterilizing.
Claim 7
Dependent Claim
23 words
The method of claim 4 in which the individual felt hemostats are packaged in moisture proof strippable packages, and sterilized by ethylene oxide.
References Cited (Backward Citations)
US3122479A
Cited
US2896618A
Cited
US3017990A
Cited
US3150416A
Cited
US3875937A
Cited
US3463158A
Cited
US3739773A
Cited
US3545442A
Cited
US3507943A
Cited
US3478141A
Cited
US3797499A
Cited
US3736646A
Cited
US3883901A
Cited
US4003758A
Cited
US3949130A
Cited
US3902497A
Cited
US3903882A
Cited
US4005169A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-12-04 | 1982-06-05 | 1982-12-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-12-04 | 1986-06-05 | 1986-12-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-12-04 | 1990-06-05 | 1990-12-05 | $7700.00 | Window Closed / Lapsed |